Treatments of palpebral congenital melanocytic nevus: a systematic review

Purpose: Palpebral congenital melanocytic nevi (PCMN) is a rare congenital skin lesion affecting the eyelids that can lead to cosmetic and psychological concerns and potential health risks such as malignancy. Several authors have analyzed therapeutical strategies to treat PCMN. However, there was no consensus in the literature. This systematic review aimed to evaluate the effectiveness, safety, and success of treatments of PCMN. Methods: We conducted a systematic review following PRISMA guidelines from October 2022 to April 2023. We included all types of study designs that described or compared PCMN treatments and interventions, as well as histology, recurrence, adverse events, patient satisfaction, and malignant transformation. The search strategy was based on specific search words through the following databases: PubMed, Embase, Latin American and Caribbean Health Sciences Literature (Lilacs), Web of Science, and Scopus. Ongoing studies and gray literature studies were included. Results: We analyzed 25 case reports with 148 participants. The effectiveness, success, and satisfaction with various treatments for PCMN depend on the specific treatment method and the individual patient's case. Conclusions: Most of the studies showed that surgical procedures (exeresis) are able to treat PCMN in the eyelid. The variability in outcomes emphasizes the importance of further research to better understand the most effective and safe approaches for treating congenital melanocytic nevi.

Seguridad del HeberFERON( en pacientes con carcinoma basal palpebral / Safety of HeberFERON in patients with basal cell eyelid carcinoma

Objetivo: Evaluar la seguridad del HeberFERON( en el tratamiento del carcinoma basal palpebral. Métodos: Se realizó un estudio descriptivo en pacientes con carcinoma basal palpebral, a quienes se les aplicó HeberFERON( perilesional, de enero del año 2013 a enero de 2018. La muestra quedó constituida por 20 pacientes que cumplieron los criterios de inclusión. La dosis protocolizada fue de 3,5 x 106 UI, perilesional, dos veces a la semana por 5 semanas consecutivas. Las variables del estudio fueron: edad, sexo, color de la piel, localización del tumor, así como tipo y grado de evento adverso. Para todas las variables del estudio fueron calculadas las frecuencias absolutas y relativas. Resultados: La población estudiada con carcinoma basal palpebral mostró mayor frecuencia entre los 60 y 79 años de edad (80 por ciento) y las lesiones se presentaron fundamentalmente en el párpado inferior (60 (). El eritema palpebral y el dolor en el sitio de la inyección constituyeron los eventos adversos oculares más frecuentes (95,0 y 70,0 por ciento respectivamente) y se presentaron en el 95 por ciento de los pacientes investigados. Los eventos adversos sistémicos (fiebre, artralgia y la cefalea) prevalecieron en el 100 por ciento de los casos, en quienes el grado de severidad fue leve. Conclusiones: El HeberFERON( en el tratamiento del carcinoma basal palpebral es una buena alternativa no quirúrgica; es seguro y bien tolerado(AU)

Objective: Evaluate the safety of HeberFERON in the treatment of basal cell eyelid carcinoma. Methods: A descriptive study was conducted of patients with basal cell eyelid carcinoma undergoing perilesional HeberFERON therapy from January 2013 to January 2018. The sample was composed of 20 patients meeting the inclusion criteria. The protocol dose was 3.5 x 106 UI perilesional twice a week for five consecutive weeks. The variables analyzed were age, sex, skin color and tumor location, as well as adverse event type and degree. Absolute and relative frequencies were estimated for all the study variables. Results: The prevailing age group in the study basal cell eyelid carcinoma population was 60-79 years (80 percent). The most common lesion site was the lower eyelid (60 percent). Eyelid erythema and injection site pain were the most frequent ocular adverse events (95.0 percent and 70.0 percent, respectively), presenting in 95 percent of the study subjects. Systemic adverse events (fever, arthralgia and headache) prevailed in 100 percent of the cases studied, among whom the degree of severity was mild. Conclusions: HeberFERON is a good non-surgical alternative for basal cell eyelid carcinoma. It is safe and well tolerated(AU)

Respuesta clínica del tratamiento con HerberFERON( en pacientes con carcinoma basal palpebral / Clinical response to treatment with HerberFERON® in patients with basal palpebral carcinoma

Objetivo: Determinar la respuesta clínica en pacientes con carcinoma basal palpebral tratados con HeberFERON. Métodos: Se realizó un estudio descriptivo en pacientes con carcinoma basal palpebral, a quienes se les aplicó HeberFERON( perilesional en el Instituto Cubano de Oftalmología "Ramón Pando Ferer", de enero del año 2013 a enero de 2015. La muestra quedó constituida por 10 pacientes que cumplieron con los criterios de inclusión. Las variables del estudio fueron: edad, sexo, color de la piel, forma clínica, diámetro tumoral, subtipo histológico del tumor, así como la respuesta clínica después del tratamiento de los casos estudiados. Para todas las variables del estudio fueron calculadas las frecuencias absolutas y relativas. Resultados: Predominaron el género masculino y los sujetos de piel blanca. En los pacientes estudiados se presentaron la forma clínica nódulo ulcerativo, el subtipo histológico tumoral poco diferenciado y la respuesta clínica objetiva. Conclusiones: En la mayoría de los pacientes se logró una buena respuesta clínica al tratamiento con HeberFERON(, por lo que este tratamiento se convierte una nueva alternativa no quirúrgica(AU)

Objective: To determine the clinical response in patients with basal palpebral carcinoma treated with HeberFERON(. Methods: A descriptive study was carried out in patients with eyelid cell basal carcinoma tried with HeberFERON in the Cuban Institute of Ophthalmology "Ramón Pando Ferrer" from January 2013 to January 2015. The sample consisted of 10 patients who fulfilled the inclusion criteria. The study variables were: age, sex, skin color, clinical form, tumor diameter, histological subtype of the tumor, as well as the clinical response after treatment of the cases studied. In all the variables, absolute and relative frequencies were calculated. Results: Male gender and white-skinned subjects predominated. The clinical form ulcerative nodule, poorly differentiated histological tumor subtype, and objective clinical response were present in the patients studied. Conclusions: In most of the patients a good clinical answer was achieved to the treatment with HeberFERON, which becomes a new non surgical alternative(AU)

Reconstrucción palpebral inferior mediante colgajo de periostio y colgajo de Mustardé / Lower palpebral reconstruction by periosteum flap and Mustardé flap

Paciente masculino de 68 años con carcinoma basocelular lobulado recidivado en inferior izquierdo con colgajo de Hughes hace 5 años y posterior recidiva al siguiente año con escisión en cuña. Actualmente, con una segunda recidiva, se realiza una resección amplia del 75% del total del párpado cuya congelación informa márgenes libres, reconstruido en el mismo acto quirúrgico: la lamela posterior con colgajo pediculado de periostio y la anterior con un colgajo de Mustardé. El paciente evoluciona con un buen sostén y posición palpebral, sin recurrencia del tumor.

A 68-year-old man with recurrent lobulated basal cell carcinoma of the left lower eyelid. She has a history of reconstruction of the lower left eyelid with Hughes flap 5 year sago and later recurrence the following year with wedge excision. Currently, with a second recurrence, resection was performed under frozen section technique and the defect of 75% width free of tumor, is reconstructed in the same surgical act: the posterior lamella with a pedicled periosteal flap and the anterior with a Mustardé flap. One year follow-up, the patient evolves with good support and eyelid position, without recurrence of the tumor.

Xantogranuloma juvenil gigante: acometimento palpebral difuso e simultâneo / Giant Juvenile Xanthogranuloma: diffuse and simultaneous palpebral involvement

O xantogranuloma juvenil (XGJ) é um tumor benigno e o mais comum do grupo das doenças histiocitárias proliferativas nãoLangerhans. Lesões; 2cm são consideradas XGJ gigantes, com relatos de lesões de até 18cm. Lesões oculopalpebrais podem necessitar de tratamento cirúrgico para controle de sintomas. Esse trabalho relata o caso de um menino de 8 anos que teve as 4 pálpebras acometidas por XGJ gigantes, além do terço médio. Ele foi submetido a 3 ressecções, sendo uma bastante profunda, necessitando enxerto de pele de espessura total diretamente sobre o músculo levantador da pálpebra superior. Posteriormente, 3 procedimentos de lipoenxertia foram realizados, atingindo resultado funcional e estético adequado, sem recorrência lesional.

Juvenile xanthogranuloma (JXG) is the most common benign tumor of the group of non-Langerhans histiocytic proliferative diseases. Lesions >2 cm are considered giant JXG, with reports of lesions of up to 18 cm. Oculopalpebral lesions may require surgical treatment to control symptoms. This study reports a case of an 8-year-old boy who had four eyelids and the middle third of the face affected by giant JXG. He underwent three resections, one of which was of great depth that required a full-thickness skin graft directly on the levator palpebrae superioris muscle. Subsequently, four fat-grafting procedures were performed and adequate functional and

Atypical presentation of fibroepithelial polyp: a report of two cases / Apresentação atípica de pólipo fibroepitelial: um relato de dois casos

ABSTRACT Fibroepithelial polyps are benign non-epithelial tumors arising from mesodermal tissue and are commonly found on the skin. They can develop on the eyelid and surrounding area and rarely appear at other sites. While most cutaneous cases are diagnosed incidentally, the lesions may be symptomatic based on their location. The etiology of fibroepithelial polyps is not fully understood but may involve trauma, chronic irritation, allergic factors, and developmental or congenital causes. Although fibroepithelial polyps are benign lesions, they can be malignant in extremely rare cases. Herein we discuss 2 cases of fibroepithelial polyp with an atypical presentation and their treatment.

RESUMO Pólipos fibroepiteliais são tumores benignos não-epiteliais que surgem do tecido mesodérmico e são comumente encontrados na pele. Eles podem se desenvolver na pálpebra e na área adjacente, e raramente aparecem em outros locais. Embora a maioria dos casos cutâneos seja diagnosticada incidentalmente, as lesões podem ser sintomáticas com base em sua localização. A etiologia dos pólipos fibroepiteliais não é completamente compreendida, mas pode envolver trauma, irritação crônica, fatores alérgicos e causas de desenvolvimento ou congênitas. Apesar dos pólipos fibroepiteliais serem lesões benignas, podem ser malignos em casos extremamente raros. Aqui discutimos 2 casos de pólipo fibroepitelial com uma apresentação atípica e seu tratamento.

Carcinoma de glándulas sebáceas palpebrales / Carcinoma of palpebral sebaceous glands

El carcinoma de glándulas sebáceas es un tumor altamente maligno y potencialmente letal. Puede enmascarar enfermedades inflamatorias como blefaritis, blefaroconjuntivitis, meibomitis, tarsitis y chalazión recurrente. Por eso, ante la presencia de una lesión palpebral de presentación atípica o recidivante se impone una exéresis completa con margen oncológico para su estudio anatomopatológico. Esta afección cursa con un diagnóstico clínico difícil, y en ocasiones inadvertido, por lo que se realizó una revisión bibliográfica para profundizar en sus diferentes formas de presentación, pronóstico y tratamiento.

The sebaceous gland carcinoma is a highly malignant tumor and potentially lethal; it may masquerade inflammatory diseases such as blepharitis, blepharoconjunctivitis, meibomitis, tarsitis and recurrent chalazion. Hence, the presence of palpebral injury of recurrent or atypical presentation imposes a complete resection with oncological margin for pathological examination. This condition presents with difficult clinical diagnosis and sometimes unnoticed, so we conducted a literature review to delve into its various forms of presentation, prognosis and treatment.

Comportamiento de los tumores malignos de los párpados en el Instituto Nacional de Oncología y Radiobiología / Behavior of malignant eyelid tumors treated at the National Institute of Oncology and Radiobiology

Objetivo: evaluar el comportamiento clínico-histopatológico de los tumores malignos palpebrales y las modalidades de tratamiento aplicadas en el Instituto Nacional de Oncología y Radiobiología. Métodos: se realizó un análisis retrospectivo de 255 pacientes tratados consecutivamente en el periodo de enero 1995 a julio 2010. Los casos fueron evaluados según localización del tumor, modalidad de tratamiento, recurrencias, recidivas, complicaciones y sobrevida. El estadiamiento se realizó según los criterios de la la Unión Internacional contra el Cáncer como T1N0M0, T2N0M0, T3N0M0, T4N0M0. Resultados: del total de pacientes, 54,1 por ciento fueron masculinos y 45,9 por ciento femeninos con rangos de edad entre 18 y 80 años. La localización más frecuente fue en el párpado inferior (35 por ciento), y el canto externo, la variedad histopatológica predominante fue el carcinoma basocelular (47,8 por ciento). El tratamiento de elección fue la cirugía, la que se realizó a 198 pacientes. El 50,2 por ciento de los casos tratados tuvieron persistencia tumoral con infiltración de los bordes de sección quirúrgicos, los cuales recibieron tratamiento radiante adyuvante. Se presentaron recurrencias en el 3,5 porciento entre 3 y 5 meses y recidivas en el 7,1 por ciento de los casos, a partir del primer año después de terminado el tratamiento inicial, las complicaciones más frecuentes encontradas fueron los pobres resultados cosméticos, disminución de la visión, úlceras corneales, entre otras. La sobrevida fue de 86,3 porciento. Conclusiones: se hace necesaria la introducción de modernos y conservadores tratamientos como alternativa a la cirugía que sean capaces de controlar el tumor y mejorar la calidad de vida de los pacientes con cáncer palpebral en casos específicos

Objective: to evaluate the clinical and histopathological behavior of malignant eyelid tumors and the treatment options followed at the National Institute of Oncology and Radiobiology. Methods: a retrospective analysis of 255 patients consecutively treated from January 1995 to July 2010 was carried out. The cases were evaluated according to location of tumor, treatment modality, recurrence, relapse, complications and survival rate. The staging of each case followed the criteria of the International Union against Cancer such T1N0M0, T2N0M0, T3N0M0, T4N0M0. Results: of the total number of patients, 54.1percent were males and 45.9percent females with age ranging 18 to 80 years. The most frequent location was the lower eyelid (35percent) and the outer border, the predominant histopathological type was basocellular carcinoma (47.8 percent). The treatment of choice was surgery which was performed in 198 patients. In the study group, 50.2 percent of the treated cases showed tumoral persistence with infiltration of surgical section borders, which received adjuvant radiant treatment. Recurrences occurred in 3.5 percent of cases after 3 to 5 months and relapses appeared in 7.1 percent of patients after the first year of the end of the initial treatment. The most common complications were poor esthetic results, reduced vision, corneal ulcers and others. Survival rate was 86.3 percent. Conclusions: it is necessary to implement modern and conservative treatments as alternative to surgery, which may be able to control tumor and to improve the quality of life of specific eyelid cancer cases

Uso da biomembrana de látex em cavidade exenterada: relato de caso / The use of latex biomembrane in exenteration: case report

A membrana de látex é um material extraído da Hevea brasiliensis, e devido às suas propriedades neoangiogênicas, de adesão celular e formação de matriz extracelular, é utilizada em recobrimentos de úlceras, meringoplastias e outras feridas, com sucesso. Neste caso descrevemos seu uso, inédito, na ferida pós-exenteração orbitária por carcinoma basocelular em paciente do sexo masculino, 72 anos, procedente da Bahia com lesão na pálpebra do olho esquerdo há dois anos com prurido, sangramento, lacrimejamento, e dor. Ao exame oftalmológico do olho esquerdo evidenciou-se lesão ulcerada de pálpebra superior e canto medial, hiperemia conjuntival, afilamento corneano, catarata, perfuração ocular. Sem alterações significativas à direita. A tomografia de órbitas revelou lesão expansiva palpebral com invasão pré-septal, osso frontal e lâmina papirácea à esquerda. Realizada exenteração total com curativo de biomembrana de látex; troca a cada 24 horas nos primeiros sete dias e a cada 48 horas nos outros sete dias. Retirou-se a biomembrana de látex por não ter sido evidenciada granulação, o que só ocorreu após um mês e quinze dias. A exenteração orbitária consiste na retirada de todo o conteúdo da órbita, incluindo olho e partes moles. É considerada total quando as pálpebras são incluídas, e subtotal quando as mesmas são preservadas. Existem várias técnicas de reconstrução da cavidade exenterada: como granulação espontânea, enxerto de pele, retalho frontal, retalho miocutâneo, entre outros. Neste caso utilizamos curativo com biomembrana de látex, material que se mostrou eficaz no recobrimento de outros tecidos cruentos como úlceras, mas sem o mesmo sucesso em nossa experiência. Mais estudos são necessários para que possamos concluir as vantagens e desvantagens do uso da biomembrana de látex na área da oftalmologia.

The latex biomembrane is a material from Hevea brasiliensis and has angiogenic properties, cellular adhesion and extracellular matrix formation. It has been used for the treatment of ulcers in the inferior extremities caused by diabetes, chronic vascular insufficiency and timpanic perforations. In this study we report a case of biomembrane use to promote granulation in the orbital cavity after exenteration in a male, 72 years, who came into our service with a left eyelid lesion for two years. The ocular examination revealed a hyperemic conjunctiva, corneal thinning, cataract and ocular perforation in the left eye. The right eye had no alterations. There was an expansive and ulcerated lesion with orbital septum, frontal bone and lamina papiracea invasion confirmed by tomography. A total exenteration of the cavity was made and the biomembrane was applied to the affected site. Changes were made every 24 hours in the first seven days, and every other day in the following seven days. The biomembrane had to be taken from the patient because no granulation could be seen. Just one occurred and a half month later. Exenteration is a procedure in which all of the orbital content is removed. If the eyelids are included it is called total exenteration. There are many exenteration techniques as spontaneous granulation, skin grafts, miocutaneous flap, etc. In this case we used a material which has been successfully applied for other wounds, but with no efficiency in our experience. More studies are necessary so that we can present benefits to our patients in the ophthalmologic area with the latex biomembrane.

Linfoma de células da zona do manto em anexos oculares: relato de caso / Mantle-cell lymphoma of the ocular adnexa: a case report

Os tumores linfóides dos anexos oculares são neoplasias de crescimento lento que acometem principalmente idosos. O objetivo deste trabalho é relatar um caso de linfoma não-Hodgkin de células da zona do manto, um subtipo raro de linfoma de células B nos anexos oculares. RELATO DO CASO: Paciente masculino de 62 anos com tumoração em pálpebras superiores, região maxilar e cavidade oral, tendo o diagnóstico inicial de doença de Mikulics, evoluiu com acentuado aumento das lesões, apesar da terapêutica imunossupressora. Biopsias da pálpebra superior esquerda e medula óssea revelaram linfoma não-Hodgkin de células B da zona do manto. Apesar da disseminação (estadiamento grau IV), quimioterapia e transplante de medula óssea conduziram à remissão da doença. COMENTARIOS CONCLUSIVOS: Apesar da disponibilidade de avançados métodos diagnósticos complementares como a imunofenotipagem e a análise genética molecular, o linfoma representa, para clínicos e patologistas, um desafio quanto ao diagnóstico e ao prognóstico.

Crioterapia en pequeños tumores malignos palpebrales / Cryotherapy in small malignant eyelids tumors

Para determinar la efectividad de la crioterapia como tratamiento del cáncer de los párpados, se realizó un análisis descriptivo de tipo retrospectivo de 10 pacientes con diagnóstico clínico de carcinoma palpebral cuyo máximo tamaño de la lesión fue de 5 mm y que no fuese pigmentado. El 60 por ciento de los pacientes se encontraba entre los 31 y los 60 años de edad y el 80 por ciento pertenece al sexo femenino. El párpado superior estuvo afectado en un 80 por ciento y el 90 por ciento de las lesiones fueron por clínica diagnosticadas como carcinoma basocelular.y respondieron al tratamiento. La crioterapia es un tratamiento efectivo y curativo en pequeños tumores palpebrales

Hemangioma da infância, infiltraçäo intralesional de triamcinolona; nossa experiência com 13 casos / Capilar hemangioma in children, intralesional corticosteroid (triamcinolone) infiltration; our experience with 13 cases

Apresentaçäo de experiências em 13 casos de crianças portadoras de hemangioma capilar palpebral e orbitário tratados com infiltraçäo intralesional de triamcinolona. Em todos os casos foram observados regressäo acentuada da tumoraçäo, com melhora rápida da fisiologia palpebral, da estética e de outros aspectos, tais como proptose, estrabismo, ptose, etc. Näo foram detectados clinicamente quaisquer efeitos colaterais

Crioterapia en carcinomas de células basales palpebrales / Cryotherapy in eyelid basal cell carcinomas

La crioterapia con nitrógeno líquido en spray aparece como una alternativa terapéutica en lesiones tumorales palpebrales. Desde 1979, se usa dicho procedimiento en 32 pacientes confirmados de tener carcinoma basocelular palpebral. 6 hombres y 26 mujeres. Edad promedio 67 años (entre 17 y 86 años). Su evolución previa fue de 3,6 años. El tratamiento consistió en una o dos aplicaciones. La recuperación a cada aplicación demoró más de 4 semanas. para el seguimiento se descartaron 10 casos por tener menos de 6 meses de control, por cambio de procedimiento terapéutico o por extensión intraorbitaria. En los 22 casos el seguimiento promedio fue de 37 meses, con recidiva en 3 casos (13.6%). En todos los casos se produjo despigmentación y pérdida de pestañas